NO20030649L - Komplekser inneholdende perfluoralkyl med polare radikaler, fremgangsmåterfor fremstilling og anvendelse derav - Google Patents

Komplekser inneholdende perfluoralkyl med polare radikaler, fremgangsmåterfor fremstilling og anvendelse derav

Info

Publication number
NO20030649L
NO20030649L NO20030649A NO20030649A NO20030649L NO 20030649 L NO20030649 L NO 20030649L NO 20030649 A NO20030649 A NO 20030649A NO 20030649 A NO20030649 A NO 20030649A NO 20030649 L NO20030649 L NO 20030649L
Authority
NO
Norway
Prior art keywords
preparation
methods
complexes containing
containing polar
polar radical
Prior art date
Application number
NO20030649A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030649D0 (no
Inventor
Johannes Platzek
Peter Mareski
Ulrich Niedballa
Bernd Raduechel
Hanns-Joachim Weinmann
Bernd Misselwitz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20030649D0 publication Critical patent/NO20030649D0/no
Publication of NO20030649L publication Critical patent/NO20030649L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20030649A 2000-08-11 2003-02-10 Komplekser inneholdende perfluoralkyl med polare radikaler, fremgangsmåterfor fremstilling og anvendelse derav NO20030649L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10040858A DE10040858C2 (de) 2000-08-11 2000-08-11 Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung
PCT/EP2001/008500 WO2002013875A2 (de) 2000-08-11 2001-07-23 Perfluoralkylhaltige komplexe mit polaren resten, verfahren zu deren herstellung und ihre verwendung

Publications (2)

Publication Number Publication Date
NO20030649D0 NO20030649D0 (no) 2003-02-10
NO20030649L true NO20030649L (no) 2003-04-11

Family

ID=7653176

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030649A NO20030649L (no) 2000-08-11 2003-02-10 Komplekser inneholdende perfluoralkyl med polare radikaler, fremgangsmåterfor fremstilling og anvendelse derav

Country Status (30)

Country Link
EP (1) EP1307237B9 (bg)
JP (1) JP2004506026A (bg)
KR (2) KR20030022381A (bg)
CN (1) CN1468113A (bg)
AR (1) AR035342A1 (bg)
AT (1) ATE359093T1 (bg)
AU (2) AU7977701A (bg)
BG (1) BG107541A (bg)
BR (1) BR0113187A (bg)
CA (1) CA2419259A1 (bg)
CZ (1) CZ2003341A3 (bg)
DE (2) DE10040858C2 (bg)
DK (1) DK1307237T3 (bg)
EE (1) EE200300060A (bg)
ES (1) ES2284671T3 (bg)
HR (1) HRP20030171A2 (bg)
HU (1) HUP0300769A3 (bg)
IL (1) IL154329A0 (bg)
MX (1) MXPA03001286A (bg)
NO (1) NO20030649L (bg)
NZ (1) NZ524080A (bg)
PL (1) PL365367A1 (bg)
PT (1) PT1307237E (bg)
RU (1) RU2289579C2 (bg)
SK (1) SK286239B6 (bg)
UA (1) UA74004C2 (bg)
UY (1) UY26873A1 (bg)
WO (1) WO2002013875A2 (bg)
YU (1) YU10503A (bg)
ZA (1) ZA200301947B (bg)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344704B2 (en) 2002-07-10 2008-03-18 Schering Ag Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of intravascular thrombi
DE10231799B4 (de) * 2002-07-10 2006-10-05 Schering Ag Verwendung von perfluoralkylhaltigen Metallkomplexen als Kontrastmittel im MR-Imaging zur Darstellung von Intravasalen Thromben
UY29663A1 (es) * 2005-07-15 2007-02-28 Schering Ag Complejos metalicos con contenido de perfluoroalquilo, procedimientos para su preparacion, así como su uso
DE102005033902B3 (de) * 2005-07-15 2007-04-05 Schering Ag Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel
DE102005033903B4 (de) * 2005-07-15 2007-08-09 Bayer Schering Pharma Ag Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel
DE102006049821A1 (de) * 2006-10-18 2008-04-24 Bayer Schering Pharma Aktiengesellschaft Metallchelate mit perfluoriertem PEG-Rest, Verfahren zu deren Herstellung, sowie deren Verwendung
DE102007015598A1 (de) * 2007-03-29 2008-10-02 Heinrich-Heine-Universität Düsseldorf Verwendung von fluorhaltigen Verbindungen zu Diagnosezwecken mit Hilfe bildgebender Verfahren
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
RU2755181C2 (ru) 2016-11-28 2021-09-14 Байер Фарма Акциенгезельшафт Новые хелатные соединения гадолиния с высокой релаксивностью для применения в магнитно-резонансной визуализации
RU2681319C1 (ru) * 2017-10-27 2019-03-06 Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский экономический университет имени Г.В. Плеханова" (ФГБОУ ВО "РЭУ им. Г.В. Плеханова") Ультраволокнистый биополимерный материал с бактерицидным эффектом
MX2021006024A (es) 2018-11-23 2021-07-06 Bayer Ag Formulacion de medios de contraste y proceso para prepararlos.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4317588C2 (de) * 1993-05-24 1998-04-16 Schering Ag Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19608278A1 (de) * 1996-02-23 1997-08-28 Schering Ag Pharmazeutische Mittel enthaltend perfluoralkylhaltige Metallkomplexe, und ihre Verwendung in der Tumortherapie und interventioniellen Radiologie
DE19729013A1 (de) * 1997-07-03 1999-02-04 Schering Ag Oligomere, perfluoralkylhaltige Verbindungen, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19744004C1 (de) * 1997-09-26 1999-07-22 Schering Ag Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging

Also Published As

Publication number Publication date
BG107541A (bg) 2004-01-30
DE10040858C2 (de) 2003-12-18
JP2004506026A (ja) 2004-02-26
KR20080027397A (ko) 2008-03-26
WO2002013875A3 (de) 2002-08-22
KR20030022381A (ko) 2003-03-15
DE10040858A1 (de) 2002-03-28
HUP0300769A3 (en) 2009-03-02
UY26873A1 (es) 2002-03-22
SK1552003A3 (en) 2003-09-11
CN1468113A (zh) 2004-01-14
AU7977701A (en) 2002-02-25
MXPA03001286A (es) 2004-04-20
BR0113187A (pt) 2003-07-01
AU2001279777B2 (en) 2006-08-31
PT1307237E (pt) 2007-07-02
SK286239B6 (sk) 2008-06-06
HRP20030171A2 (en) 2004-06-30
YU10503A (sh) 2006-08-17
AR035342A1 (es) 2004-05-12
NO20030649D0 (no) 2003-02-10
EP1307237B1 (de) 2007-04-11
CZ2003341A3 (cs) 2003-05-14
IL154329A0 (en) 2003-09-17
EP1307237B9 (de) 2008-01-09
ATE359093T1 (de) 2007-05-15
PL365367A1 (en) 2004-12-27
NZ524080A (en) 2005-10-28
UA74004C2 (en) 2005-10-17
CA2419259A1 (en) 2002-02-21
ES2284671T3 (es) 2007-11-16
HUP0300769A2 (hu) 2003-09-29
EP1307237A2 (de) 2003-05-07
DK1307237T3 (da) 2007-07-02
WO2002013875A2 (de) 2002-02-21
EE200300060A (et) 2004-12-15
DE50112336D1 (de) 2007-05-24
RU2289579C2 (ru) 2006-12-20
ZA200301947B (en) 2004-06-25

Similar Documents

Publication Publication Date Title
MXPA03006010A (es) Derivados de arilamina sustituida y metodos de uso.
NO20011964D0 (no) Brönnbehandlingsfluider og fremgangsmåter med anvendelse derav
IS6934A (is) Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
IS2485B (is) Fenýlsúlfónýl-1,3-díhýdró-2H-indól-2-ón afleiður,framleiðsla þeirra og notkun í meðferðarskyni
NO20041216L (no) Imidazol-4-karboksamidderivater, fremstilling og anvendelse derav for behandling av overvekt
IS7041A (is) 5-HT viðtakabindlar og notkun þeirra
NO20033387D0 (no) Modifiserte antistoffer og fremgangsmåter for anvendelse
IS6661A (is) Bensimídasólafleiður, framleiðsla þeirra og meðferðarleg notkun
DK1329456T3 (da) Glucopyranosyloxybenzylbenzenderivater og medicinske sammensætninger indeholdende samme
DK1404809T3 (da) Forbedrede hudsubstitutter og anvendelser deraf
DK1233964T3 (da) Ny anvendelse og hidtil ukendte N-azabicycloamidderivater
IS5756A (is) Notkun hreinljósvirks (+) -norkisapríðs við meðhöndlun á öndunarstöðvun, lotugræðgi og öðrum meinum
DK1379224T3 (da) Guanylat-cyclase receptor-agonister til behandling af vævsinflammation og carciogenese
IS8422A (is) Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun þeirra
IS8219A (is) Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun
DK1392292T3 (da) Pyranoindazoler og deres anvendelse til behandling af glaukom
NO20041004L (no) Fremgangsmate og anordning for sammensetting av gjenfestbare absorberende klesplagg
NO20030649L (no) Komplekser inneholdende perfluoralkyl med polare radikaler, fremgangsmåterfor fremstilling og anvendelse derav
DK1417189T3 (da) Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf
IS7579A (is) Píperasínýlasýlpíperidín afleiður, framleiðsla þeirra og meðferðar notkun þeirra
IS2867B (is) Neublastín sem tengt er fjölliðu og aðferðir við notkun þess
IS7052A (is) Amínókínólín- og amínópýridínafleiður og notkun þeirra sem adenósín A3 bindlar
EP1392280A4 (en) ARYLSULFONAMIDE ETHERS AND METHODS OF USE THEREOF
IS2331B (is) 2-arýlimínó-2,3-díhýdróþíasólafleiður, aðferðir til að framleiða þær og meðferðarfræðileg notkun þeirra
NO20005919D0 (no) Platinakompleks, dets fremstilling og terapeutisk anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application